Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03 interim results of a randomised, active-controlled, observer-blinded, phase 3 trial
Jeong, Su Jin, Lee, Jacob, Kwon, Ki Tae, Choi, Hee Jung, Sohn, Jang Wook, Kim, Young Keun, Yoo, Byung Wook, Jang, In-Jin, Capeding, Maria Z., Roman, Francois, Breuer, Thomas, Wysocki, Piotr, Carter, Lauren, Sahastrabuddhe, Sushant, Song, Manki, D`Cor, Naveena, Kim, Hun, Ryu, Ji Hwa, Lee, Su Jeen, Park, Yong Wook, Cheng, Hee Jin, Song, Joon Young, Choi, Won Suk, Heo, Jung Yeon, Kim, Eun Jin, Lee, Jin Soo, Jung, Dong Sik, Kim, Shin -Woo, Park, Kyung-Hwa, Eom, Joong Sik
ECLINICALMEDICINE, 202310